SCHEMBL2177965

SCHEMBL2177965

COc1ccc2cc(-c3ccnc(NCCc4ccc(OC)c(OC)c4)n3)cc(N3CCN(c4ncnc5[nH]nc(Br)c45)CC3)c2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNT1 O60563 2/20 0.42
CCNA2 P20248 2/20 0.42
CDK2 P24941 2/20 0.42
CDK9 P50750 2/20 0.42
MAPT P10636 9/20 0.40
TSHR P16473 5/20 0.40
LMNA P02545 4/20 0.40
TP53 P04637 4/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
HTT P42858 2/20 0.40
MAPK1 P28482 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
GAA P10253 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
ALOX15 P16050 2/20 0.38
POLB P06746 2/20 0.37
CRHBP P24387 1/20 0.37
CRHR2 Q13324 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2176226 0.92 MKNK1 (0.41) CCNT1CCNA2CDK2CDK9DYRK1A
SCHEMBL2177179 0.88 EIF2AK2 (0.36) CCNT1CDK9DYRK1ACLK4ADRA1D
SCHEMBL2180818 0.86 MKNK1 (0.39) MEN1KMT2APOLBDYRK1ACLK4
SCHEMBL2178372 0.85 RPS6KB1 (0.37) CCNA2CDK2RPS6KB1AKT1
SCHEMBL2176973 0.83 CCNT1 (0.50) CCNT1CCNA2CDK2CDK9MAPT
SCHEMBL2179737 0.83 MEN1 (0.56) CCNT1CCNA2CDK2CDK9MAPT
SCHEMBL2175611 0.82 CCNT1 (0.47) CCNT1CCNA2CDK2CDK9MAPT
SCHEMBL2178137 0.80 SLC2A1 (0.46) CCNT1CCNA2CDK2CDK9MAPT
SCHEMBL2179106 0.78 DYRK1A (0.52) CCNT1CCNA2CDK2CDK9MEN1
SCHEMBL2179548 0.78 DYRK1A (0.49) CCNT1CCNA2CDK2CDK9DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US claimed
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US disclosed
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US disclosed
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds ARQULE, INC. (US) 2011-07-07 US disclosed
WO-2011082268-A2 SUBSTITUTED NAPHTHALENYL-PYRIMIDINE COMPOUNDS ARQULE INC. (US) 2011-07-07 WO disclosed
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds ARQULE, INC. (US) 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds DPYD, TP53, TYMP CCNT1 53/4885CCNA2 66/4885CDK2 23/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.